Drugs with New Product Regulatory Exclusivity
Click here to include patents covering these drugs in this list
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Exclusivity Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | Start Trial | NEW PATIENT POPULATION | |
| Sun Pharma Global | BROMSITE | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 206911-001 | Apr 8, 2016 | RX | Yes | Yes | Start Trial | NEW PRODUCT | |
| Avedro Inc | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | Start Trial | NEW PRODUCT | |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Exclusivity Expiration | >Patented / Exclusive Use |
